iNKT: A new avenue for CAR-based cancer immunotherapyYilin Liu, Huizhong Li, Junnian Zheng et al.|Translational Oncology|2022Cited by 50
IL-21-armored B7H3 CAR-iNKT cells exert potent antitumor effectsY Liu, Huizhong Li, Yuanyuan Dang et al.|iScience|2023Cited by 26